Literature DB >> 33814838

Island Nasolabial Flap for Tongue Reconstruction: Locoregional Flap of Choice and an Alternative to Free Flap for Tongue Cancer.

Vikas Sharma1,2, Sandhya Pandey3, Ajeet Kumar Gandhi4, Arun Pandey5, Madhup Rastogi4, Rohini Sethi4, Rahat Hadi4, Nuzhat Hussain6.   

Abstract

Reconstruction following excision for tongue cancer carries important functional consequences. Island nasolabial flap (NLF) is robust and oncologically safe and has a good functional outcome, identical to free flap reconstruction. We retrospectively analyzed the data of 11 tongue cancer patients operated between January 2019 and August 2019. Surgical resection and neck dissection followed by immediate reconstruction by island NLF were done. Post-operative functional outcome assessed using the University of Washington Quality of Life Questionnaire. Age of patients ranged between 39 and 70 years. All patients had either T2 or T3 tongue cancer. No incidence of flap necrosis noted in any patient. On an average, all were discharged between 3rd and 5th post-operative days. Cosmetic and functional outcomes were satisfactory in all patients. Island nasolabial has an excellent reach and can reach any part of the oral cavity, even to the contralateral side and base of the tongue. It has an excellent post-operative tongue function, almost equivalent to free flap. Hence, it should be considered locoregional flap of choice for tongue reconstruction. © Indian Association of Surgical Oncology 2020.

Entities:  

Keywords:  Island nasolabial flap; Tongue cancer

Year:  2020        PMID: 33814838      PMCID: PMC7960853          DOI: 10.1007/s13193-020-01214-3

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  10 in total

1.  Nasolabial flaps in oral reconstruction: an analysis of 224 cases.

Authors:  B T Varghese; P Sebastian; T Cherian; P M Mohan; I Ahmed; C M Koshy; S Thomas
Journal:  Br J Plast Surg       Date:  2001-09

Review 2.  Free-Flap Reconstruction of the Tongue.

Authors:  Aurora Vincent; Scott Kohlert; Thomas S Lee; Jared Inman; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2019-03-08       Impact factor: 2.314

3.  An unusual complication of nasolabial flap reconstruction.

Authors:  R Mann; B Srinivasan; R Webb; A Webb
Journal:  Ann R Coll Surg Engl       Date:  2016-10-28       Impact factor: 1.891

4.  The nasolabial tunnel flap.

Authors:  N G Georgiade; R A Mladick; F L Thorne
Journal:  Plast Reconstr Surg       Date:  1969-05       Impact factor: 4.730

5.  Esser's skin flap for closing large palatal fistulae.

Authors:  A F Wallace
Journal:  Br J Plast Surg       Date:  1966-10

6.  Use of nasolabial skin flap to cover intraoral defects.

Authors:  R A Elliott
Journal:  Plast Reconstr Surg       Date:  1976-08       Impact factor: 4.730

7.  Nasolabial pedicled compared with island flaps for intraoral reconstruction of oncological defects: complications, recovery of sensitivity, and assessment of quality of life.

Authors:  Lazaridou Maria; Vaxtsevanos Konstantinos; Dimitrakopoulos Ioannis; Lazaridis Nikolaos; Antoniades Konstantinos
Journal:  Br J Oral Maxillofac Surg       Date:  2016-05-12       Impact factor: 1.651

8.  Evaluation of swallowing function after intraoral soft tissue reconstruction with microvascular free flaps.

Authors:  I Hara; N-C Gellrich; J Düker; R Schön; M Nilius; O Fakler; R Schmelzeisen; S Ozeki; T Honda
Journal:  Int J Oral Maxillofac Surg       Date:  2003-12       Impact factor: 2.789

9.  Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing.

Authors:  F M McConnel; B R Pauloski; J A Logemann; A W Rademaker; L Colangelo; D Shedd; W Carroll; J Lewin; J Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-06

10.  Swallowing function in patients who underwent hemiglossectomy: comparison of primary closure and free radial forearm flap reconstruction with videofluoroscopy.

Authors:  Hung-Tao Hsiao; Yi-Shing Leu; Shih-Hsin Chang; Jui-Tien Lee
Journal:  Ann Plast Surg       Date:  2003-05       Impact factor: 1.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.